• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Assessment of Molecular, Antigenic, and Pathological Features of Canine Influenza A(H3N2) Viruses That Emerged in the United States

tetano

Editor, Senior Moderator
J Infect Dis. 2017 Sep 15;216(suppl_4):S499-S507. doi: 10.1093/infdis/jiw620.
[h=1]Assessment of Molecular, Antigenic, and Pathological Features of Canine Influenza A(H3N2) Viruses That Emerged in the United States.[/h] Pulit-Penaloza JA[SUP]1[/SUP], Simpson N[SUP]1[/SUP], Yang H[SUP]1[/SUP], Creager HM[SUP]1[/SUP], Jones J[SUP]1[/SUP], Carney P[SUP]1[/SUP], Belser JA[SUP]1[/SUP], Yang G[SUP]1[/SUP], Chang J[SUP]1[/SUP], Zeng H[SUP]1[/SUP], Thor S[SUP]1[/SUP], Jang Y[SUP]1[/SUP], Killian ML[SUP]2[/SUP], Jenkins-Moore M[SUP]2[/SUP], Janas-Martindale A[SUP]2[/SUP], Dubovi E[SUP]3[/SUP], Wentworth DE[SUP]1[/SUP], Stevens J[SUP]1[/SUP], Tumpey TM[SUP]1[/SUP], Davis CT[SUP]1[/SUP], Maines TR[SUP]1[/SUP].
[h=3]Author information[/h]

[h=3]Abstract[/h] [h=4]Background:[/h] A single subtype of canine influenza virus (CIV), A(H3N8), was circulating in the United States until a new subtype, A(H3N2), was detected in Illinois in spring 2015. Since then, this CIV has caused thousands of infections in dogs in multiple states.
[h=4]Methods:[/h] In this study, genetic and antigenic properties of the new CIV were evaluated. In addition, structural and glycan array binding features of the recombinant hemagglutinin were determined. Replication kinetics in human airway cells and pathogenesis and transmissibility in animal models were also assessed.
[h=4]Results:[/h] A(H3N2) CIVs maintained molecular and antigenic features related to low pathogenicity avian influenza A(H3N2) viruses and were distinct from A(H3N8) CIVs. The structural and glycan array binding profile confirmed these findings and revealed avian-like receptor-binding specificity. While replication kinetics in human airway epithelial cells was on par with that of seasonal influenza viruses, mild-to-moderate disease was observed in infected mice and ferrets, and the virus was inefficiently transmitted among cohoused ferrets.
[h=4]Conclusions:[/h] Further adaptation is needed for A(H3N2) CIVs to present a likely threat to humans. However, the potential for coinfection of dogs and possible reassortment of human and other animal influenza A viruses presents an ongoing risk to public health.


[h=4]KEYWORDS:[/h] CIV; H3N2; canine influenza; ferrets; transmission

PMID: 28934454 DOI: 10.1093/infdis/jiw620
 
Back
Top Bottom